기업

버텍스

주관 임상 32건 · 진행 중 31건 · FDA 승인 0

주관 임상 단계 분포

3상141상62상51/2상32/3상24상1단계 미표기1

진행 중인 임상

  • 3상모집 예정협력· Opioid Consumption, Postoperative

    Assessing Suzetrigine for Pain Reduction Following Ureteroscopic Surgery

    NCT07654296
  • 4상모집 예정협력· Knee Arthritis

    Role of Suzetrigine as a Part of a Multimodal Regimen to Reduce Pain and Opioid Use After Total Knee Arthroplasty

    NCT07624526
  • 1상모집 중· Narcolepsy Type 1 (NT1)

    A Phase 1, First-in-human Study of VX-433

    NCT07584434
  • 2상모집 중· Myasthenia Gravis, Generalized

    A Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis

    NCT07501702
  • 1상모집 중단 (진행 중)· Pain

    Effects of Efavirenz on the Pharmacokinetics of Suzetrigine in Healthy Participants

    NCT07570069
  • 4상모집 중· Pain

    Evaluation of Pain Treatment After Total Knee Arthroplasty

    NCT07538570
  • 1상모집 중· Cystic Fibrosis

    Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-272 in Healthy Participants

    NCT07437105
  • 1상모집 중· Pain

    Evaluation of the Excretion of Suzetrigine Into Breast Milk in Healthy Lactating Female Participants

    NCT07378865
  • 1상모집 중· Cystic Fibrosis

    Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-581 in Healthy Participants

    NCT07283770
  • 3상모집 중· Diabetic Peripheral Neuropathic Pain

    Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy

    NCT07231419
  • 2상모집 중· Autosomal Dominant Polycystic Kidney Disease (ADPKD)

    Phase 2a Study of VX-407 in Participants With ADPKD Who Have a Subset of PKD1 Gene Variants (AGLOW)

    NCT07161037
  • 2/3상모집 중· Primary Membranous Nephropathy

    Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)

    NCT07204275
  • 3상모집 중· Type 1 Diabetes

    An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant

    NCT06832410
  • 2상모집 중단 (진행 중)· Proteinuric Kidney Disease

    Inaxaplin in Participants With Proteinuric APOL1 Mediated Kidney Disease With or Without Comorbidities

    NCT06794996
  • 단계 미표기모집 중단 (진행 중)· Autosomal Dominant Polycystic Kidney Disease (ADPKD)

    Polycystic Kidney Disease 1 (PKD1) Gene Variant Groups in Autosomal Dominant Polycystic Kidney Disease

    NCT06747572
  • 3상모집 중단 (진행 중)· Diabetic Peripheral Neuropathic Pain

    Evaluation of the Long-term Safety and Effectiveness of Suzetrigine (SUZ) in Participants With Painful Diabetic Peripheral Neuropathy (DPN)

    NCT06696443
  • 3상모집 중단 (진행 중)· Cystic Fibrosis

    Evaluation of Long-term Safety and Efficacy of ELX/TEZ/IVA in Cystic Fibrosis Participants 12 Months of Age and Older

    NCT06460506
  • 2상모집 중· Diabetic Peripheral Neuropathic Pain

    Evaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral Neuropathy

    NCT06619860
  • 3상모집 중· Diabetic Peripheral Neuropathic Pain

    Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy

    NCT06628908
  • 1/2상모집 중· Myotonic Dystrophy Type 1 (DM1)

    A Phase 1/2 Study of VX-670 in Adult Participants With Myotonic Dystrophy 1 (DM1)

    NCT06185764

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.